Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07288359
What this trial is testing

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals 205
Not applicableNot Yet RecruitingNCT07190703
What this trial is testing

Research on Early Diagnosis and Risk Stratification Biomarkers of Anti-Tumor Drug-Associated Interstitial Pneumonia Driven by Multi-Omics Integration

Who this might be right for
Anti-Tumor Drug-Associated Interstitial Pneumonia
Fuzhou University Affiliated Provincial Hospital 200
Early research (Phase 1)UnknownNCT05843305
What this trial is testing

BPI-452080 in Subjects With Solid Tumors

Who this might be right for
Solid TumorRenal Cell CarcinomaVon Hippel-Lindau Disease
Betta Pharmaceuticals Co., Ltd. 87
Testing effectiveness (Phase 2)UnknownNCT03992170
What this trial is testing

Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive

Who this might be right for
Myeloma Multiple
Azienda Ospedaliera Universitaria Senese 50
Testing effectiveness (Phase 2)Ended earlyNCT00017069
What this trial is testing

Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
CTI BioPharma
Not applicableUnknownNCT04552054
What this trial is testing

Mixed Reality Technique Combined With 3D Printing Navigational Template for Localizing Pulmonary Nodules

Who this might be right for
Video-assisted Thoracic SurgeryLung CancerPulmonary Nodule, Solitary+1 more
Wen-zhao ZHONG 136
Not applicableStudy completedNCT03981679
What this trial is testing

Circulating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay.

Who this might be right for
Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 278
Early research (Phase 1)Study completedNCT02561962
What this trial is testing

Study in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 42
Large-scale testing (Phase 3)Study completedNCT02292446
What this trial is testing

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals 161
Not applicableNot Yet RecruitingNCT06745427
What this trial is testing

A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

Who this might be right for
Endometrial CancerEndometrial Intraepithelial NeoplasiaFertility-sparing Surgery
Region Stockholm 100
Large-scale testing (Phase 3)Study completedNCT02997202
What this trial is testing

A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 356
Early research (Phase 1)Study completedNCT02826772
What this trial is testing

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Suzhou Kintor Pharmaceutical Inc, 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05994001
What this trial is testing

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Who this might be right for
Biliary Tract CancerCandonilimabClaudin 18.2
Shanghai Zhongshan Hospital 78
Large-scale testing (Phase 3)Not Yet RecruitingNCT06146777
What this trial is testing

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

Who this might be right for
Papillary Renal Cell Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 468
Not applicableStudy completedNCT05091437
What this trial is testing

DOuBLED - Doubling Outcomes by Lung Cancer Early Diagnosis

Who this might be right for
Pulmonary Nodules
AstraZeneca 562
Not applicableStudy completedNCT01471639
What this trial is testing

An Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain

Who this might be right for
Other Acute Pain
The Cleveland Clinic 37
Testing effectiveness (Phase 2)UnknownNCT04877275
What this trial is testing

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Who this might be right for
Multiple Myeloma
Chunyan Sun, MD 50
Early research (Phase 1)Study completedNCT01122875
What this trial is testing

The Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genentech, Inc. 14
Not applicableLooking for participantsNCT05866757
What this trial is testing

Discontinuation Study

Who this might be right for
Multiple MyelomaCancerHematologic Cancer
University College Cork 70
Testing effectiveness (Phase 2)Ended earlyNCT03093831
What this trial is testing

Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma

Who this might be right for
Lymphoma, B-Cell, Marginal Zone
National Cancer Centre, Singapore 5
Next Page